OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex proteins. Optimizing these processes involves adjusting various factors, including cell line engineering, media composition, and bioreactor settings. A key goal is to maximize antibody production while reducing production expenses